Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMDstem: hiPSC-CM Modeling of Pediatric Genetic Cardiomyopathy
NCT03696628Completed
- Sponsor
- CHU Montpellier
- Start
- Sep 2017
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Open-label trial in Familial cardiomyopathy (FCM) (2 arms), sponsored by CHU Montpellier. Primary endpoint: human induced pluripotent stem cell-derived cardiomyocytes culture. Started Sep 2017; status: completed.
02
Conditions
Familial cardiomyopathy (FCM)
Beyond the preview
Go deeper on NCT03696628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696628.